Gestational Response, Outcomes, and Weight After GLP-1 Use

Conditions: Pregnant Individuals, Obesity & Overweight, Gestational Weight Gain

Sex: Female

Ages: 18 Years – 45 Years

Healthy volunteers: Yes

Enrollment: 400

Sponsor: University of Kansas Medical Center

Location: University of Kansas Medical Center Kansas City Kansas

Summary

The goal of this observational study is to learn if using GLP-1RA medications for weight loss before pregnancy influences gestational weight gain and pregnancy outcomes. The main aims of the study are to: * Compare gestational weight gain between women with preconception GLP-1RA exposure and those without exposure. * Compare obstetrical outcomes between women with preconception GLP-1RA exposure and those without exposure. Researchers will compare pregnant women with a history of GLP-1RA use to pregnant women who have not used a GLP-1RA to compare differences. Participants will be asked to complete questionnaires at multiple timepoints during and after pregnancy that ask questions about medication history, thoughts and feelings around food, etc.

Eligibility Criteria

Inclusion Criteria: * Adult women * Less than or equal to 20 weeks gestation at first visit * English speaking Exclusion Criteria: * \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07743567). StuddyBuddy aggregates publicly available trial information.